Cyclooxygenase-independent effects of aspirin on HT-29 human colon cancer cells, revealed by oligonucleotide microarrays
- 4 July 2006
- journal article
- Published by Springer Nature in Biotechnology Letters
- Vol. 28 (16) , 1263-1270
- https://doi.org/10.1007/s10529-006-9084-9
Abstract
Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) inhibit proliferation of human colon cancer cells in vitro. Transmission electron microscope detected morphological features of apoptosis in the aspirin-treated (5 mM, 72 h) HT-29 cells in which cyclooxygenoase-2 is catalytically inactive. We investigated aspirin-induced genome-wide expression changes in HT-29 cells and further studied the time- and concentration-dependent expression changes in 374 apoptosis-related genes, which is the first to show stimulation of genome-wide expression of HT-29 cells by aspirin. The most marked effects of aspirin are on ribosome assembly and rRNA metabolism, which could explain why the quasi-apoptotic morphological changes are not accompanied by a classical DNA ladder. These findings demonstrate that aspirin induces apoptosis in HT-29 cells, bolstering the hypothesis that apoptosis may be a mechanism by which NSAIDs inhibit colon carcinogenesis.Keywords
This publication has 34 references indexed in Scilit:
- Vioxx Withdrawal Alarms Cancer Prevention ResearchersJNCI Journal of the National Cancer Institute, 2004
- DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1Carcinogenesis: Integrative Cancer Research, 2004
- Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibitionOncogene, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- GenMAPP, a new tool for viewing and analyzing microarray data on biological pathwaysNature Genetics, 2002
- Aspirin‐induced activation of the NF‐κB signaling pathway: a novel mechanism for aspirin‐mediated apoptosis in colon cancer cellsThe FASEB Journal, 2001
- The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cellsEuropean Journal Of Cancer, 2000
- Drug target validation and identification of secondary drug target effects using DNA microarraysNature Medicine, 1998
- NSAIDs and risk of upper gastrointestinal bleedingThe Lancet, 1991
- EtodolacDrugs, 1986